- Filed
- Nov 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 3, 2025 | 11.18M sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$40.63M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$17.84M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $0 |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $7.5M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $103.16M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $12.12M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $139.83M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$180.35M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | −$169.6M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$160.57M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | −$152.75M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | −$146.58M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | −$137.35M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | −$126.11M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $11.14M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $17.21M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $21.05M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $17.45M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $147.53M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $12.47M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $160.88M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $15.92M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.91 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$9.98 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$2.58 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$19.14 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.91 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$9.98 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$2.58 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$19.14 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $11.04M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $15.5M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $1.65M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $6.01M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $15.56M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $25.25M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $3.89M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $28.35M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$24.78M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$38.44M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$7.59M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$6.08M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$3.18M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$31.76M |
| Net Income restated | Q3 2025 · Jun 30, 2024 | −$6.26M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$22.31M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$26.59M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$39.95M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$2.04M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$30.86M |
| Revenue | Q3 2025 · Sep 30, 2025 | $800K |
| Revenue | Q3 2025 · Sep 30, 2024 | $3.5M |
| Revenue | Q3 2025 · Sep 30, 2024 | $3.5M |